NINDS Neuroscience Funding Announcements

Application processes at NIH are changing. Applicant organizations are encouraged to start preparing for this transtion by registering with Grants.gov and NIH eRA Commons now.

---

Grants for Alzheimer's Disease Drug Discovery (R21)
Release Date: March 24, 2006
Announcement Number: PAS-06-261
Application Receipt Date:
June 1, 2006
October 1, 2006
February 16, 2007
June 16, 2007
October 16, 2007
February 16, 2008
June 16, 2008
October 16, 2008
February 16, 2009   

Funding Contact: Diane DiEuliis, Ph.D.
Program Area: Neurodegeneration

Brief Description:
Inviting qualified researchers to submit research grant applications directed toward the discovery, development, and preclinical testing in cellular, tissue, and animal models of novel compounds for the prevention and treatment of the cognitive impairment and behavioral symptoms associated with Alzheimer's disease (AD). Applications submitted to the NIH will be assigned and reviewed according to the usual NIH peer review procedures. Meritorious applications will be funded by the assigned NIH Institutes or co-funded by the assigned NIH Institute and the Institute for the Study of Aging (ISOA). NIA has set-aside $3.0 Million total costs in FY 2006 for applications sent in response to this PA.

Choose an option to view additional funding announcements

New Announcements | Research Area | RFAs Only | PAs Only | RFPs Only | Notices Only | Supplements Only | All Announcements | Archives